Global Blood Banking And Blood Products Market To Reach 31.7 Billion Dollars By 2010, According To New Report By Global Industry Analysts, Inc.

Main Category: Blood / Hematology
Also Included In: Pharma Industry / Biotech Industry
Article Date: 17 Apr 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

A spurt in new infections surfacing the world over remains a huge concern to the blood banking and blood products industry. Though awareness amongst the consumers, and health workers helped in reducing the intensity of infection, the industry is yet to free itself of the various problems such as safety, and availability of quality blood. The awareness has also resulted in the implementation of stringent safety standards for both donors, and blood screening (blood) banks to be adhered to before any transfusion. Rigorous testing and screening procedures, along with the help of new technology have sufficiently reduced the threat of diseases being transmitted through transfusions. Though the overall situation improved, instances of diseases spreading through blood transfusion are still common in the developing, and under-developed countries. Awareness campaigns in these countries have also drawn flak, with only a few donors volunteering.

Much of the growth in the Blood Banking and Blood Products market is anticipated from the United States and Europe, as stated in a recent report published by Global Industry Analysts, Inc. The two regions collectively account for 2/3rds of the global market. The market in Asia-Pacific projected to grow between 4-5% over the period 2001-2010. In terms of product segment, blood components and plasma products market is the largest with an estimated share of 81% in 2008. The segment is also projected to be the fastest growing with a CAGR of 4.9% over 2001-2010. Automated blood collection and processing systems and unraveling prion-screening abilities of new assays are s! et to revolutionize the blood safety setup, both by increasing the blood quality and the quantity of blood collected through painless and sophisticated instruments. Several modifications in the purchasing system in the European market have provided hospitals with more bargaining power. Whole blood & cellular components market in Europe is estimated at $7.5 billion in 2008.

The report profiles major blood banks by region. Leading players in blood bank technology and supplies, profiled in the report include Beckman Coulter Inc, Becton Dickinson, Bio Products Laboratory, Chiron Corporation, Chiron Blood Testing, CSL Behring, Daxor Corporation, Fresenius Group, Gambro BCT, Gen-Probe Incorporated, Grifols, Haemonetics, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation , ThermoGenesis Corp., and ZymeQuest, Inc.,

The report titled "Blood Banking and Blood Products: A Global Strategic Business Report" published by Global Industry Analysts, Inc. analyzes the market in Millions of US dollar by the following geographic regions - United States, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World. The study also enumerates recent developments, mergers, acquisitions, and other strategic industry activities.

For more details about this research report, please visit click here.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

http://www.StrategyR.com